Year |
Citation |
Score |
2014 |
Sahar S, Masubuchi S, Eckel-Mahan K, Vollmer S, Galla L, Ceglia N, Masri S, Barth TK, Grimaldi B, Oluyemi O, Astarita G, Hallows WC, Piomelli D, Imhof A, Baldi P, et al. Circadian control of fatty acid elongation by SIRT1 protein-mediated deacetylation of acetyl-coenzyme A synthetase 1. The Journal of Biological Chemistry. 289: 6091-7. PMID 24425865 DOI: 10.1074/Jbc.M113.537191 |
0.61 |
|
2012 |
Hallows WC, Yu W, Denu JM. Regulation of glycolytic enzyme phosphoglycerate mutase-1 by Sirt1 protein-mediated deacetylation. The Journal of Biological Chemistry. 287: 3850-8. PMID 22157007 DOI: 10.1074/Jbc.M111.317404 |
0.648 |
|
2011 |
Hallows WC, Yu W, Smith BC, Devries MK, Devires MK, Ellinger JJ, Someya S, Shortreed MR, Prolla T, Markley JL, Smith LM, Zhao S, Guan KL, Denu JM. Sirt3 promotes the urea cycle and fatty acid oxidation during dietary restriction. Molecular Cell. 41: 139-49. PMID 21255725 DOI: 10.1016/J.Molcel.2011.01.002 |
0.667 |
|
2011 |
Smith BC, Settles B, Hallows WC, Craven MW, Denu JM. SIRT3 substrate specificity determined by peptide arrays and machine learning. Acs Chemical Biology. 6: 146-57. PMID 20945913 DOI: 10.1021/Cb100218D |
0.643 |
|
2010 |
Someya S, Yu W, Hallows WC, Xu J, Vann JM, Leeuwenburgh C, Tanokura M, Denu JM, Prolla TA. Sirt3 mediates reduction of oxidative damage and prevention of age-related hearing loss under caloric restriction. Cell. 143: 802-12. PMID 21094524 DOI: 10.1016/J.Cell.2010.10.002 |
0.588 |
|
2010 |
Ariyannur PS, Moffett JR, Madhavarao CN, Arun P, Vishnu N, Jacobowitz DM, Hallows WC, Denu JM, Namboodiri AM. Nuclear-cytoplasmic localization of acetyl coenzyme a synthetase-1 in the rat brain. The Journal of Comparative Neurology. 518: 2952-77. PMID 20533355 DOI: 10.1002/Cne.22373 |
0.526 |
|
2010 |
Arun P, Madhavarao CN, Moffett JR, Hamilton K, Grunberg NE, Ariyannur PS, Gahl WA, Anikster Y, Mog S, Hallows WC, Denu JM, Namboodiri AM. Metabolic acetate therapy improves phenotype in the tremor rat model of Canavan disease. Journal of Inherited Metabolic Disease. 33: 195-210. PMID 20464498 DOI: 10.1007/S10545-010-9100-Z |
0.525 |
|
2009 |
Smith BC, Hallows WC, Denu JM. A continuous microplate assay for sirtuins and nicotinamide-producing enzymes. Analytical Biochemistry. 394: 101-9. PMID 19615966 DOI: 10.1016/J.Ab.2009.07.019 |
0.634 |
|
2009 |
Hallows WC, Smith BC, Lee S, Denu JM. Ure(k)a! Sirtuins Regulate Mitochondria. Cell. 137: 404-6. PMID 19410538 DOI: 10.1016/J.Cell.2009.04.036 |
0.696 |
|
2008 |
Smith BC, Hallows WC, Denu JM. Mechanisms and molecular probes of sirtuins. Chemistry & Biology. 15: 1002-13. PMID 18940661 DOI: 10.1016/J.Chembiol.2008.09.009 |
0.632 |
|
2008 |
Hallows WC, Albaugh BN, Denu JM. Where in the cell is SIRT3?--functional localization of an NAD+-dependent protein deacetylase. The Biochemical Journal. 411: e11-3. PMID 18363549 DOI: 10.1042/Bj20080336 |
0.655 |
|
2006 |
Hallows WC, Lee S, Denu JM. Sirtuins deacetylate and activate mammalian acetyl-CoA synthetases. Proceedings of the National Academy of Sciences of the United States of America. 103: 10230-5. PMID 16790548 DOI: 10.1073/Pnas.0604392103 |
0.67 |
|
Low-probability matches (unlikely to be authored by this person) |
2013 |
Brennan KC, Bates EA, Shapiro RE, Zyuzin J, Hallows WC, Huang Y, Lee HY, Jones CR, Fu YH, Charles AC, PtáÄek LJ. Casein kinase iδ mutations in familial migraine and advanced sleep phase. Science Translational Medicine. 5: 183ra56, 1-11. PMID 23636092 DOI: 10.1126/Scitranslmed.3005784 |
0.296 |
|
2016 |
Hirano A, Shi G, Jones CR, Lipzen A, Pennacchio LA, Xu Y, Hallows WC, McMahon T, Yamazaki M, Ptáček LJ, Fu YH. A Cryptochrome 2 Mutation Yields Advanced Sleep Phase in Human. Elife. 5. PMID 27529127 DOI: 10.7554/Elife.16695 |
0.255 |
|
2013 |
Hallows WC, PtáÄek LJ, Fu YH. Solving the mystery of human sleep schedules one mutation at a time. Critical Reviews in Biochemistry and Molecular Biology. 48: 465-75. PMID 24001255 DOI: 10.3109/10409238.2013.831395 |
0.249 |
|
2023 |
Hallows WC, Skvorak K, Agard N, Kruse N, Zhang X, Zhu Y, Botham RC, Chng C, Shukla C, Lao J, Miller M, Sero A, Viduya J, Ismaili MHA, McCluskie K, et al. Optimizing human α-galactosidase for treatment of Fabry disease. Scientific Reports. 13: 4748. PMID 36959353 DOI: 10.1038/s41598-023-31777-4 |
0.225 |
|
2016 |
Hirano A, Shi G, Jones CR, Lipzen A, Pennacchio LA, Xu Y, Hallows WC, McMahon T, Yamazaki M, Ptáček LJ, Fu Y. Author response: A Cryptochrome 2 mutation yields advanced sleep phase in humans Elife. DOI: 10.7554/Elife.16695.018 |
0.216 |
|
2020 |
Hallows WC, Skvorak K, Zhu CY, Sero A, Botham R, Agard N, Chng C, Dellas N, Miller M, Shin J, Viduya J, Zhang X, Schiffmann R, Huisman G, McCluskie K, et al. Engineering α-galactosidase A (GLA) to improve protein stability, efficacy and reduced immune response for the treatment of Fabry disease Molecular Genetics and Metabolism. 129: S69. DOI: 10.1016/J.Ymgme.2019.11.164 |
0.086 |
|
Hide low-probability matches. |